The Potential CC16 (Clara Cell Protein 16) as Biomarkers of Lung Damage in COVID-19 Survivors: Literature Review
Abstract
CC16 or Clara cell secretory protein-16 is a protein produced from the secretion of respiratory epithelial club cells, especially in the lungs. CC16 in several studies has anti-inflammatory effects and plays an important role in potential biomarkers and pathogenesis of chronic lung damage. One of the main respiratory diseases that attacks the lungs is COVID-19 (Coronavirus disease 2019). COVID-19 survivors had significantly decreased serum CC16 levels. The purpose of this review is to draw conclusions based on findings based on research results on the potential of CC16 as a biomarker of lung damage in COVID-19 survivors. This research used a literature review of research published from 2019-2023 in electronic media, such as ProQuest, Science Direct, CINAHL, and Pubmed. The number of Randomized controlled trials (RCTs) research articles obtained was seven articles that met the criteria. The research subjects of the study involved COVID-19 survivors. The keywords used Clara cell secretory protein-16 (CC16), a biomarker of lung damage, and COVID-19 survivor. They revealed that serum CC16 levels were found to be a potential damage or biomarker of lung disease in COVID-19 survivors. This review concluded that CC16's structure and the possible formation of mechanisms molecular and cellular can inhibit inflammation and in clinical applications are thought to be potential biomarkers and therapeutic targets of respiratory disease or chronic lung damage. Future research is required to investigate this hemoprotein in the circulation of COVID-19 survivors.
Keywords: Biomarker, CC16, COVID-19 survivors, Clara cell protein-16
Full Text:
PDFReferences
Almuntashiri, S., James, C., Wang, X., Siddiqui, B., & Zhang, D. (2021). The potential of lung epithelium specific proteins as biomarkers for covid-19-associated lung injury. In Diagnostics (Vol. 11, Nomor 9). https://doi.org/10.3390/DIAGNOSTICS11091643
Almuntashiri, S., Zhu, Y., Han, Y., Wang, X., Somanath, P. R., & Zhang, D. (2020). Club cell secreted protein CC16: Potential applications in prognosis and therapy for pulmonary diseases. In Journal of Clinical Medicine (Vol. 9, Nomor 12). https://doi.org/10.3390/jcm9124039
Andreeva, E., Lallemand, V., Purnal, A., Reyhanitabar, R., Roy, A., & Vizár, D. (2021). Forkcipher: A New Primitive for Authenticated Encryption of Very Short Messages. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 11922 LNCS, 153–182. https://doi.org/10.1007/978-3-030-34621-8_6
Andreeva, E., Pokhasnikova, M., Lebedev, A., Moiseeva, I., Kozlov, A., Kuznetsova, O., & Degryse, J. M. (2021). Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD). Journal of Thoracic Disease, 13(8). https://doi.org/10.21037/jtd-20-1580
Combes, A., Dekerle, J., Dumont, X., Twomey, R., Bernard, A., Daussin, F., & Bougault, V. (2019). Continuous exercise induces airway epithelium damage while a matched-intensity and volume intermittent exercise does not. Respiratory Research, 20(1). https://doi.org/10.1186/s12931-019-0978-1
Cui, B., Ma, Y., & Chen, Z. H. (2022). The role and clinical application prospect of CC16 in the pathogenesis of chronic airway disease. In Fudan University Journal of Medical Sciences (Vol. 49, Nomor 2). https://doi.org/10.3969/j.issn.1672-8467.2022.02.019
Eklund, L., Schagatay, F., Tufvesson, E., Sjöström, R., Söderström, L., Hanstock, H. G., Sandström, T., & Stenfors, N. (2021). An experimental exposure study revealing composite airway effects of physical exercise in a subzero environment. International Journal of Circumpolar Health, 80(1). https://doi.org/10.1080/22423982.2021.1897213
Fazal, M. (2021). C-Reactive Protein a Promising Biomarker of COVID-19 Severity. The Korean Journal of Clinical Laboratory Science, 53(3). https://doi.org/10.15324/kjcls.2021.53.3.201
Hasegawa, M., Fujimoto, M., Hamaguchi, Y., Matsushita, T., Inoue, K., Sato, S., & Takehara, K. (2011). Use of serum Clara cell 16-kDa (CC16) Levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis. Journal of Rheumatology, 38(5). https://doi.org/10.3899/jrheum.100591
Iqbal, P., Jamshaid, M. B., Shahzad, A., Yousaf, Z., Monfared, S. N., Sadik, N. D., & Hassan, I. F. (2022). Enigma of categorizing COVID-19-related lung parenchymal diseases and management experience with follow-up outcomes in Qatar: a case series. Qatar Medical Journal, 2022(1). https://doi.org/10.5339/qmj.2022.2
Kaur, M., Tiwari, S., & Jain, R. (2020). Protein based biomarkers for non-invasive Covid-19 detection. Sensing and Bio-Sensing Research, 29. https://doi.org/10.1016/j.sbsr.2020.100362
Kerschbaumer, I., Fazzari, M., Burstein, S. R., Furey, A., Fox, A. S., Cole, A. M., Gendlina, I., Gendlina, I., & Achkar, J. M. (2021). 313. Host Protein Biomarkers Predicting Severity of Lung Damage due to COVID-19. Open Forum Infectious Diseases, 8(Supplement_1). https://doi.org/10.1093/ofid/ofab466.515
Khadzhieva, M. B., Gracheva, A. S., Ershov, A. V., Chursinova, Y. V., Stepanov, V. A., Avdeikina, L. S., Grebenchikov, O. A., Babkina, A. S., Shabanov, A. K., Tutelyan, A. V., Petrikov, S. S., & Kuzovlev, A. N. (2021). Biomarkers of air-blood barrier damage in covid-19. Obshchaya Reanimatologiya, 17(3). https://doi.org/10.15360/1813-9779-2021-3-2-0
Liu, M., Lu, J., Zhang, Q., Zhang, Y., & Guo, Z. (2021). Clara cell 16 KDa protein mitigates house dust mite-induced airway inflammation and damage via regulating airway epithelial cell apoptosis in a manner dependent on HMGB1-mediated signaling inhibition. Molecular Medicine, 27(1). https://doi.org/10.1186/s10020-021-00277-4
McKay, K., Wayland, S., Ferguson, D., Petty, J., & Kennedy, E. (2021). “At Least until the Second Wave Comes … ”: A Twitter Analysis of the NHS and COVID-19 between March and June 2020. International Journal of Environmental Research and Public Health, 18(8). https://doi.org/10.3390/ijerph18083943
Méndez, A., Rojas, D. A., Ponce, C. A., Bustamante, R., Beltrán, C. J., Toledo, J., García-Angulo, V. A., Henriquez, M., & Vargas, S. L. (2019). Primary infection by Pneumocystis induces Notch-independent Clara cell mucin production in rat distal airways. PLoS ONE, 14(6). https://doi.org/10.1371/journal.pone.0217684
Miyama, T., Iritani, N., Nishio, T., Ukai, T., Satsuki, Y., Miyata, H., Shintani, A., Hiroi, S., Motomura, K., & Kobayashi, K. (2021). Seasonal Shift in Epidemics of Respiratory Syncytial Virus Infection in Japan. Epidemiology and Infection. https://doi.org/10.1017/S0950268821000340
Pourmanaf, H., Hamzehzadeh, A., & Nikniaz, L. (2020). The effect of physical preparedness levels on serum levels of CC16, SP-D and lung function in endurance runners. Science and Sports, 35(4). https://doi.org/10.1016/j.scispo.2019.10.006
Rohmann, N., Stürmer, P., Geisler, C., Schlicht, K., Hartmann, K., Türk, K., Hollstein, T., Tran, F., Rosenstiel, P., Franke, A., Heyckendorf, J., Schreiber, S., Schulte, D. M., & Laudes, M. (2022). Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1037115
Rong, B., Fu, T., Gao, W., Li, M., Rong, C., Liu, W., & Liu, H. (2020). Reduced serum concentration of cc16 is associated with severity of chronic obstructive pulmonary disease and contributes to the diagnosis and assessment of the disease. International Journal of COPD, 15. https://doi.org/10.2147/COPD.S230323
Sibila, O., Perea, L., Albacar, N., Moisés, J., Cruz, T., Mendoza, N., Solarat, B., Lledó, G., Espinosa, G., Barberà, J. A., Badia, J. R., Agustí, A., Sellarés, J., & Faner, R. (2022). Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respiratory Research, 23(1). https://doi.org/10.1186/s12931-022-01955-5
Sibila Vidal, O., Albacar, N., Perea, L., Garcia, T., Mendoza, N., Cruz, T., Casas, S., Moisés, J., Badia, J. R., Barberà, J. A., Agustí, A., Sellarés, J., Faner, R., & Perea Soriano, L. (2021). Systemic SP-A is increased in COVID-19 patients with abnormal diffusion capacity 6 months after hospital discharge. https://doi.org/10.1183/13993003.congress-2021.oa85
Vlachou, M., Drebes, A., Candilio, L., Weeraman, D., Mir, N., Murch, N., Davies, N., & Coghlan, J. G. (2021). Pulmonary thrombosis in Covid-19: before, during and after hospital admission. Journal of Thrombosis and Thrombolysis, 51(4). https://doi.org/10.1007/s11239-020-02370-7
Wang, J., Zhao, Y., Pan, L., He, X., & Zhang, X. (2021). The relationship between the expression of serum IL-18 mRNA, CC16, and sTREM-1 and the severity and prognosis of ventilator-associated pneumonia in elderly patients. Annals of Palliative Medicine, 10(12). https://doi.org/10.21037/apm-21-3511
Wong, S. C., Lam, G. K. M., Auyeung, C. H. Y., Chan, V. W. M., Wong, N. L. D., So, S. Y. C., Chen, J. H. K., Hung, I. F. N., Chan, J. F. W., Yuen, K. Y., & Cheng, V. C. C. (2021). Absence of nosocomial influenza and respiratory syncytial virus infection in the coronavirus disease 2019 (COVID-19) era: Implication of universal masking in hospitals. Infection Control and Hospital Epidemiology, 42(2). https://doi.org/10.1017/ice.2020.425
Wymant, C., Ferretti, L., Tsallis, D., Charalambides, M., Abeler-Dörner, L., Bonsall, D., Hinch, R., Kendall, M., Milsom, L., Ayres, M., Holmes, C., Briers, M., & Fraser, C. (2021). The epidemiological impact of the NHS COVID-19 app. Nature, 594(7863). https://doi.org/10.1038/s41586-021-03606-z
Xu, W., & Song, Y. (2017). Biomarkers for patients with trauma associated acute respiratory distress syndrome. In Military Medical Research (Vol. 4, Nomor 1). https://doi.org/10.1186/s40779-017-0134-5
Zhang, S., Jia, Q., Song, J., Tan, Q., Yu, G., Guo, X., & Zhang, H. (2020). Clinical significance of cc16 and il-12 in bronchoalveolar lavage fluid of various stages of silicosis. Annals of Palliative Medicine, 9(6). https://doi.org/10.21037/apm-20-1838
DOI: http://dx.doi.org/10.30829/contagion.v4i2.15454
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Fika Tri Anggraini
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
